after stopping semaglutide How to Stop Rebound Weight Gain Taking Stopping Semaglutide: How to Keep

45 Interestingly, overall proportion of patients experiencing at least 1 adverse event was similar across treatment groups

Reviews in Endocrine and Metabolic Disorders

The SURMOUNT trials showed tirzepatide producing average weight loss of 20 to 22.5 percent at the highest dose over 72 weeks, compared to semaglutide 14.9 percent in STEP 1

risk may be higher with rapid weight loss

Severe complications from semaglutide remain uncommon, with fewer than 4 emergency department visits per 1,000 patients reported in a Harvard-CDC study

Serious Health Complications Linked to Wegovy Some Wegovy patients in Louisiana have reported having severe side effects and medical problems